Reimagining Inflammation: A Road to New Therapies?

13.01.2016
Share article

Many of the medical conditions and leading causes of death facing our population involve some form of chronic inflammation; which acts like a prolonged on-switch for the immune system. Heart disease, cancer, diabetes, Alzheimer’s disease and abnormal wound healing are among prominent illnesses in which chronic inflammation plays key a role.

In many tissue types there is a reserve of stem cells that is responsible for supporting the healing process after normal inflammation has occurred or an injury has taken place. However, it has not been as widely explored under chronic inflammation conditions. A recent study published in Nature Cell Biology takes a new look at the concept of chronic inflammation and proposes its potential use as a method for new therapies.

The study was conducted by researchers at Ecole polytechnique fédérale de Lausanne (EPFL), described as Europe’s most cosmopolitan technical university with students, professors and staff from over 120 nations. The team of scientists at EPFL’s Swiss Institute for Experimental Cancer Research (ISREC) have discovered that chronic inflammation can lead to metaplasia or the ability for cells to actually change type. In the case of this study, eye cells made a dramatic transformation into skin cells!

Using a corneal epithelium mouse model, chronic inflammation was simulated and the method of fluorescent staining of specific cells was used to help observe and analyze stem cells located in the cornea. Chronic inflammation led to a “stiffer” environment due to the presence of both immune cells and also a substance that causes cells to stick together. The corneal stem cells possess sensors which allow them to sense their environment, make proper adaptations or adjustments and also communicate with other cells. The increased stiffness of their surroundings led the stem cells to not only respond to the changing environment but to actually improperly differentiate.

As a result, instead of differentiating into corneal cells, the faulty programming resulted in the stem cells differentiating into skin cells leading to blindness in the mice. The lead researcher, Freddy Radtke describes the discovery as one that “is relevant to a variety of diseases associated with chronic inflammation, including cancer, and could yield new therapeutic targets.”

 

Image copyright: Samuel Johnson, flickr CC-BY

Article last time updated on 18.01.2016.

3 rating(s) (5 ø)
1104 Views
Medicine, Research, Studies
The maximum length of a comment is 1000 characters.
The maximum length of an alias is 30 characters.
Please enter a comment.
Please insert a valid comment!
Click here and become a medical blogger!
The findings of the team of researchers, published in Science last week, has helped identify exactly at what point more...
Understanding Microdosing The practice of microdosing has gained momentum in recent years and is defined as using 1 more...
B-lymphocytes (B-cells) and T-lymphocytes (T-cells) are the immune system cell types commonly associated with more...

Disclaimer

PR-blogs on DocCheck are sponsored blogs which are published on DocCheck by commercial providers additionally to regular userblogs. They may contain promotional statements. DocCheck is not responsible for this content.

Copyright © 2017 DocCheck Medical Services GmbH
Language:
Follow DocCheck: